Transforming growth factor beta inhibits the proliferation of the blast
cells of acute myeloblastic leukemia
N Tessier and T Hoang
Clinical Research Institute of Montreal, Quebec, Canada.
The effect of transforming growth factor beta (TGF beta) on proliferation
and differentiation of peripheral blast precursors in acute myeloblastic
leukemia (AML) was investigated. TGF beta induced a dose-dependent
inhibition of blast clonogenic cells in suspension and methylcellulose
cultures in the presence of optimal concentrations of stimulators provided
by conditioned media from the bladder cell line HTB9 (HTB9-CM) or the
recombinant granulocyte-macrophage colony- stimulating factor (GM-CSF). On
removal of TGF beta, blast clonogenic cell proliferation recovers to the
same level as that observed in control cultures, indicating that the effect
is reversible. There was no induction of cell differentiation, as indicated
by morphological and functional studies (production of superoxyde anions).
Cell cycle analysis by thymidine uptake and flow cytometry with a DNA
binding dye indicated that TGF beta caused a delay in progression into S
and G2/M phases of the cell cycle without affecting cell viability. Thus,
TGF beta appears to have a cytostatic rather than cytolytic effect on blast
precursors and might therefore play a role as a negative regulator in
hematopoiesis.
Volume 72,
Issue 1,
pp. 159-164,
07/01/1988
Copyright © 1988 by The American Society of Hematology